Nachrichten zur Indivior PLC Aktie

Narcan Owner Opiant to Be Acquired by Indivior for $145 Million

The combination of addiction-drug makers could tap into billions of dollars in settlement and federal funds aimed at expanding access…

SHAREHOLDER ALERT: Weiss Law Investigates Opiant Pharmaceuticals, Inc.

NEW YORK, Nov. 14, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of…

Shareholder Alert: Ademi LLP investigates whether Opiant Pharmaceuticals Inc. has obtained a Fair Price in its transaction with Indivior

MILWAUKEE, Nov. 14, 2022 /PRNewswire/ -- Ademi LLP is investigating Opiant (NASDAQ: OPNT) for possible breaches of fiduciary duty and…

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Opiant Pharmaceuticals Inc. (OPNT)

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - November 14, 2022) - Law office of Brodsky & Smith announces that it is investigating…

Indivior buys Opiant creating "comprehensive" treatment platform

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

Opiant Pharmaceuticals Shares Surge Premarket on Takeover by Indivior >OPNT

Opiant Pharmaceuticals Shares Surge Premarket on Takeover by Indivior >OPNT...…

Opiant surges 123% as Indivior set to acquire overdose therapy maker for $145M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Indivior swoops for US addiction specialist in US$200mln deal

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Indivior To Acquire Opiant Pharmaceuticals

Acquisition Strengthens and Extends Indiviors Position as a Leader in Addiction Treatment Opiant Pipeline Anchored by OPNT003, an Opioid Overdose…

Indivior PLC to Acquire Opiant Pharmaceuticals

SANTA MONICA, Calif., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) today announced that it…

Indivior Announces Q3 2022 Financial Results

SLOUGH, UK and RICHMOND, Va., Oct. 27, 2022 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced its financial results for…

TOP NEWS: Indivior ups annual guidance on "strong momentum"

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

Indivior Lifts 2022 Guidance After 3Q Profit, Revenue Rose

Indivior Lifts 2022 Guidance After 3Q Profit, Revenue Rose...…

XFRA : Deletion of Instruments from Boerse Frankfurt - 07.10.2022

The following instruments on Boerse Frankfurt do have their last trading day on 07.10.2022 Die folgenden Instrumente in Boerse Frankfurt haben…

XFRA : ISIN Change

Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen SE0016278196 Sectra AB 07.10.2022 SE0018245953 Sectra AB 10.10.2022 Tausch 1:1 GB00BRS65X63 Indivior PLC 07.10.2022 GB00BN4HT335 Indivior PLC 10.10.2022 Tausch 5:1 US4510332038 iBio Inc. 07.10.2022 US4510336096 iBio Inc. 10.10.2022 Tausch 25:1 US45790J8009 Inpixon 07.10.2022 US45790J8678 Inpixon 10.10.2022 Tausch 75:1...…

dpa-AFX ProFeed